Gilberto Bueno Fischer
Research Subjects
Research Interests
Gilberto Bueno Fischer has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Helena Teresinha Mocelin
Hospital da Criança Santo Antônio, Brasil
7 shared publications - Rita Mattiello
Programa de Pós-Graduação em Epidemiologia, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil
4 shared publications Edgar E. Sarria
Herman Wells Center for Pediatric Research, Indiana University, USA
2 shared publicationsAlejandro Teper
Centro Respiratorio, Hospital de Niños Ricardo Gutierrez, Argentina
1 shared publicationBelkys Rueda
Hospital El Pino; Universidade de Santiago, Chile
1 shared publicationCecília Bittencourt Severo
Pos Graduate course Universidade Federal Rio Grande do Sul - Brazil
1 shared publication
Latest Publications
- 30 October 2015
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 17, 48-49
Pleural effusions in children from Southern Brazil
- 30 October 2015
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 17, 48-49
Pleural effusions in children from Southern Brazil
- Open Access
- 23 April 2012
- Published by Fundacao Sociedade Brasileira de Pediatria in Jornal de Pediatria
- Vol. 88 (2) , 155-60
A randomized, double-blind, placebo-controlled trial of cyproheptadine for appetite stimulation in cystic fibrosis
To determine whether the administration of cyproheptadine was able to induce weight gain in patients with cystic fibrosis. We performed a double-blind, placebo-controlled trial in two centers in Brazil. Twenty-five patients with cystic fibrosis between 5 and 18 years completed the study. Patients were randomized into two groups, to receive either cyproheptadine 4 mg three times per day for 12 weeks or placebo. All data were collected at the beginning and at the end of the study period and included weight, height and spirometry. Average weight gain was 0.67 kg in the placebo group and 1.61 kg in the cyproheptadine group (p = 0.036). Body mass index (BMI) decreased 0.07 kg/m(2); in the placebo group and increased 0.46 kg/m(2); in the intervention group (p = 0.027). The change in BMI for age (z score) was -0.19 in the placebo group and +0.20 in the cyproheptadine group (p = 0.003). BMI z score decreased 0.19 in the placebo group and increased 0.2 in the cyproheptadine group (p = 0.003). Changes in pulmonary function were not statistically different. Use of cyproheptadine in cystic fibrosis patients was well tolerated, showing a significant weight gain and a significant increase in BMI after 12 weeks. A clinically relevant effect size for weight/age (z score) and body mass index for age (z score) was found. Such findings suggest that the prescription of cyproheptadine can be an alternative approach for patients who need nutritional support for a short period of time.
- 23 April 2012
- Published by Fundacao Sociedade Brasileira de Pediatria in Jornal de Pediatria
- Vol. 88 (2) , 155-60
Open AccessA randomized, double-blind, placebo-controlled trial of cyproheptadine for appetite stimulation in cystic fibrosis
To determine whether the administration of cyproheptadine was able to induce weight gain in patients with cystic fibrosis. We performed a double-blind, placebo-controlled trial in two centers in Brazil. Twenty-five patients with cystic fibrosis between 5 and 18 years completed the study. Patients were randomized into two groups, to receive either cyproheptadine 4 mg three times per day for 12 weeks or placebo. All data were collected at the beginning and at the end of the study period and included weight, height and spirometry. Average weight gain was 0.67 kg in the placebo group and 1.61 kg in the cyproheptadine group (p = 0.036). Body mass index (BMI) decreased 0.07 kg/m(2); in the placebo group and increased 0.46 kg/m(2); in the intervention group (p = 0.027). The change in BMI for age (z score) was -0.19 in the placebo group and +0.20 in the cyproheptadine group (p = 0.003). BMI z score decreased 0.19 in the placebo group and increased 0.2 in the cyproheptadine group (p = 0.003). Changes in pulmonary function were not statistically different. Use of cyproheptadine in cystic fibrosis patients was well tolerated, showing a significant weight gain and a significant increase in BMI after 12 weeks. A clinically relevant effect size for weight/age (z score) and body mass index for age (z score) was found. Such findings suggest that the prescription of cyproheptadine can be an alternative approach for patients who need nutritional support for a short period of time.
- Open Access
- 5 May 2011
- Published by Fundacao Sociedade Brasileira de Pediatria in Jornal de Pediatria
- Vol. 87 (3)
Post-infectious bronchiolitis obliterans in children
To review publications about the main features of post-infectious bronchiolitis obliterans and its history, etiology, epidemiology, risk factors, pathogenesis, histological findings, clinical presentation, complementary tests, diagnostic criteria, differential diagnosis, treatment and prognosis.
- 5 May 2011
- Published by Fundacao Sociedade Brasileira de Pediatria in Jornal de Pediatria
- Vol. 87 (3)
Open AccessPost-infectious bronchiolitis obliterans in children
To review publications about the main features of post-infectious bronchiolitis obliterans and its history, etiology, epidemiology, risk factors, pathogenesis, histological findings, clinical presentation, complementary tests, diagnostic criteria, differential diagnosis, treatment and prognosis.
- 1 March 2011
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 12 (1) , 27-30
Pleural Tuberculosis in Children
- 1 March 2011
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 12 (1) , 27-30
Pleural Tuberculosis in Children
- 1 December 2010
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 11 (4) , 233-239
Post Infectious Bronchiolitis Obliterans in Children
- 1 December 2010
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 11 (4) , 233-239
Post Infectious Bronchiolitis Obliterans in Children
- Open Access
- 1 August 2010
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 36 (4) , 453-459
Função pulmonar de crianças e adolescentes com bronquiolite obliterante pós-infecciosa
OBJETIVO: Descrever a função pulmonar de crianças e adolescentes com bronquiolite obliterante pós-infecciosa (BOPI) e avaliar potenciais fatores de risco para pior função pulmonar. MÉTODOS: A função pulmonar de 77 participantes, com idades de 8-18 anos, foi avaliada por meio de espirometria e pletismografia. Os seguintes parâmetros foram analisados: CVF, VEF1, FEF25-75%, VEF1/CVF, VR, CPT, VR/CPT, volume de gás intratorácico e specific airway resistance (sRaw, resistência específica das vias aéreas). Foi utilizada a regressão de Poisson para investigar os seguintes potenciais fatores de risco para pior função pulmonar: sexo, idade do primeiro sibilo, idade ao diagnóstico, história familiar de asma, exposição ao tabaco, tempo de hospitalização e tempo de ventilação mecânica. RESULTADOS: A idade média foi de 13,5 anos. Houve uma diminuição importante de VEF1 e FEF25-75%, assim como um aumento de VR e sRaw, característicos de doença obstrutiva das vias aéreas. Os parâmetros mais afetados e as médias percentuais dos valores previstos foram VEF1 = 45,9%; FEF25-75% = 21,5%; VR = 281,1%; VR/CPT = 236,2%; e sRaw = 665,3%. Nenhum dos potenciais fatores de risco avaliados apresentou uma associação significativa com pior função pulmonar. CONCLUSÕES: As crianças com BOPI apresentaram um padrão comum de comprometimento grave da função pulmonar, caracterizado por uma obstrução importante das vias aéreas e um expressivo aumento de VR e sRaw. A combinação de medidas espirométricas e pletismográficas pode ser mais útil na avaliação do dano funcional, assim como no acompanhamento desses pacientes. Fatores de riscos conhecidos para doenças respiratórias não parecem estar associados a pior função pulmonar em BOPI.
- 1 August 2010
- Published by FapUNIFESP (SciELO) in Jornal Brasileiro de Pneumologia
- Vol. 36 (4) , 453-459
Open AccessFunção pulmonar de crianças e adolescentes com bronquiolite obliterante pós-infecciosa
OBJETIVO: Descrever a função pulmonar de crianças e adolescentes com bronquiolite obliterante pós-infecciosa (BOPI) e avaliar potenciais fatores de risco para pior função pulmonar. MÉTODOS: A função pulmonar de 77 participantes, com idades de 8-18 anos, foi avaliada por meio de espirometria e pletismografia. Os seguintes parâmetros foram analisados: CVF, VEF1, FEF25-75%, VEF1/CVF, VR, CPT, VR/CPT, volume de gás intratorácico e specific airway resistance (sRaw, resistência específica das vias aéreas). Foi utilizada a regressão de Poisson para investigar os seguintes potenciais fatores de risco para pior função pulmonar: sexo, idade do primeiro sibilo, idade ao diagnóstico, história familiar de asma, exposição ao tabaco, tempo de hospitalização e tempo de ventilação mecânica. RESULTADOS: A idade média foi de 13,5 anos. Houve uma diminuição importante de VEF1 e FEF25-75%, assim como um aumento de VR e sRaw, característicos de doença obstrutiva das vias aéreas. Os parâmetros mais afetados e as médias percentuais dos valores previstos foram VEF1 = 45,9%; FEF25-75% = 21,5%; VR = 281,1%; VR/CPT = 236,2%; e sRaw = 665,3%. Nenhum dos potenciais fatores de risco avaliados apresentou uma associação significativa com pior função pulmonar. CONCLUSÕES: As crianças com BOPI apresentaram um padrão comum de comprometimento grave da função pulmonar, caracterizado por uma obstrução importante das vias aéreas e um expressivo aumento de VR e sRaw. A combinação de medidas espirométricas e pletismográficas pode ser mais útil na avaliação do dano funcional, assim como no acompanhamento desses pacientes. Fatores de riscos conhecidos para doenças respiratórias não parecem estar associados a pior função pulmonar em BOPI.
- 1 December 2009
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 10 (4) , 172-177
Histoplasmosis in children
- 1 December 2009
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 10 (4) , 172-177
Histoplasmosis in children
- 20 October 2008
- Published by Fundacao Sociedade Brasileira de Pediatria in Jornal de Pediatria
- Vol. 84 (4) , 323-330
Assessment of nutritional status in children and adolescents with post-infectious bronchiolitis obliterans
- 20 October 2008
- Published by Fundacao Sociedade Brasileira de Pediatria in Jornal de Pediatria
- Vol. 84 (4) , 323-330
Assessment of nutritional status in children and adolescents with post-infectious bronchiolitis obliterans
- Open Access
- 6 August 2008
- Published by Fundacao Sociedade Brasileira de Pediatria in Jornal de Pediatria
- Vol. 84 (4) , 337-343
Functional capacity assessment in children and adolescents with post-infectious bronchiolitis obliterans.
To assess functional capacity during exercise in children and adolescents with post-infectious bronchiolitis obliterans (PIBO).
- 6 August 2008
- Published by Fundacao Sociedade Brasileira de Pediatria in Jornal de Pediatria
- Vol. 84 (4) , 337-343
Open AccessFunctional capacity assessment in children and adolescents with post-infectious bronchiolitis obliterans.
To assess functional capacity during exercise in children and adolescents with post-infectious bronchiolitis obliterans (PIBO).
- 1 March 2008
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 9 (1) , 57-66
Parasitic lung infection and the paediatric lung
- 1 March 2008
- Published by Elsevier in Paediatric Respiratory Reviews
- Vol. 9 (1) , 57-66
Parasitic lung infection and the paediatric lung